New HIV drug classes on the horizon

  title={New HIV drug classes on the horizon},
  author={Alisa Opar},
  journal={Nature Reviews Drug Discovery},
For those hoping that Europe might be redressing the imbalance in R&D innovation compared with the United States, two recent reports make gloomy reading. According to a competitiveness report published in November 2006 by the European Commission’s high-level Pharmaceutical Forum, the US has established itself firmly as the key innovator in pharmaceuticals since 2000. “That dominant position continues to expand ... a disproportionate share of pharmaceutical R&D is performed in the US,” it… CONTINUE READING
7 Citations
0 References
Similar Papers

Similar Papers

Loading similar papers…